Search This Blog

Wednesday, February 27, 2019

GW Pharmaceuticals CEO: ‘Epidiolex is different from other CBD options’

In an interview on CNBC’s Mad Money, GW Pharmaceuticals CEO Justin Gover said: “We do real science and produce medicines with safety and efficacy… We’re only reporting two months of sales, so some caution is warranted… Epidiolex is different from other CBD options… We’re at the beginning of the journey with Epidiolex and looking at other uses for it… Epidiolex is not marijuana, it is CBD approved by the FDA.”

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.